Viking Therapeutics (VKTX) News Today

Company: Viking Therapeutics, Inc. (NASDAQ:VKTX)
Current Price: $26.00 (mid‐day)
Volume: 10.49M vs. avg. 4.72M
Market Cap: $2.92B | 50-day MA: $31.17 | 200-day MA: $28.71

• Positive Sentiment: Investors jumped in on bargain-hunting, sending VKTX up 5.46% on Wednesday as buyers scooped up shares following Tuesday’s steep 42% slide. Viking Therapeutics (VKTX) Rebounds on Bargain-Hunting
• Positive Sentiment: HC Wainwright reiterated its “Buy” rating and set a $102 target, underscoring confidence in Viking’s pipeline. HC Wainwright Reiterates Buy Rating for VKTX
• Positive Sentiment: MarketBeat reports that analysts maintain a consensus “Buy” on VKTX, with 10 of 14 firms recommending purchases. VKTX Given Consensus “Buy” Rating
• Neutral Sentiment: Call-option volume surged 359% on Tuesday, with 88,534 calls traded, pointing to heightened speculative interest. VKTX Sees Unusually High Options Volume
• Neutral Sentiment: Analysis of the options market shows growing open interest and strategic hedging ahead of key data readouts. A Closer Look at VKTX’s Options Market Dynamics
• Negative Sentiment: Shares crashed after mixed clinical data for obesity candidate VK2735 raised safety and tolerability concerns, sparking a broad sell-off. Here’s Why Shares in Viking Therapeutics Crashed This Week
• Negative Sentiment: VKTX tumbled 39.2% in one session as investors reacted to disappointing obesity-pill trial results, undermining near-term growth outlook. Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
• Negative Sentiment: Zacks highlights mixed post-trial results for the obesity pill, raising doubts over Viking’s development path and pressuring the stock. Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock?
• Negative Sentiment: VKTX shares gapped down sharply on August 19, intensifying sell-side calls and signaling potential for further downside. Shares Gap Down – Time to Sell?